pasireotide   Click here for help

GtoPdb Ligand ID: 2018

Synonyms: pasireotide diaspartate | Signifor® | SOM 230 | SOM 320 | SOM-230
Approved drug
pasireotide is an approved drug (FDA and EMA (2012))
Comment: Cyclic peptide analog of somatostatin. This compound is represented on ChEMBL with slightly different stereochemistry by CHEMBL3039583.
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCCC1NC(=O)C(NC(=O)C(NC(=O)C2N(C(=O)C(NC(=O)C(NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)CC(C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
Isomeric SMILES NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
InChI InChI=1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,47+,48-,49+,50+,51+/m1/s1
InChI Key VMZMNAABQBOLAK-DBILLSOUSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
SST2 receptor Rn Agonist Agonist 7.8 – 9.1 pEC50 - 1-2
pEC50 7.8 – 9.1 (EC50 1.75x10-8 – 8.6x10-10 M) [1-2]
SST2 receptor Rn Agonist Partial agonist 7.6 pEC50 - 2
pEC50 7.6 (EC50 2.33x10-8 M) [2]
SST2 receptor Rn Antagonist Antagonist <5.0 pEC50 - 1
pEC50 <5.0 (EC50 >1x10-5 M) [1]
SST5 receptor Primary target of this compound Hs Agonist Full agonist 9.8 pIC50 - 3
pIC50 9.8 [3]
SST2 receptor Primary target of this compound Hs Agonist Full agonist 9.0 pIC50 - 3
pIC50 9.0 [3]
SST3 receptor Primary target of this compound Hs Agonist Full agonist 8.8 pIC50 - 3
pIC50 8.8 [3]
SST1 receptor Primary target of this compound Hs Agonist Full agonist 8.0 pIC50 - 3
pIC50 8.0 [3]